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Abstract T h es t r i a t e dm u s c l e - s p e c i ﬁ ct r i p a r t i t em o t i f
(TRIM) proteins TRIM63/MURF1, TRIM55/MURF2 and
TRIM54/MURF3 can function as E3 ubiquitin ligases in
ubiquitin-mediatedmuscleproteinturnover.Despitethewell-
characterised role of MURF1 in skeletal muscle atrophy, the
dynamics of MURF isogene expression in the development
and early postnatal adaptationofskeletalmuscleisunknown.
Here, we show that MURF2 is the isogene most highly
expressed in embryonic skeletal muscle at E15.5, with the
50 kDa A isoform predominantly expressed. MURF1 and
MURF3 are upregulated only postnatally. Knockdown of
MURF2 p50A by isoform-speciﬁc siRNA results in delayed
myogenicdifferentiationandmyotubeformationinvitro,with
perturbation of the stable, glutamylated microtubule popula-
tion.ThisunderscoresthatMURF2playsanimportantrolein
the earliest stages of skeletal muscle differentiation and
myoﬁbrillogenesis. During further development, there is a
shift towards the 60 kDa A isoform, which dominates post-
natally. Analysis of the ﬁbre-type expression shows that
MURF2 A isoformsare predominantlyslow-ﬁbre associated,
whilst MURF1 is largely excluded from these ﬁbres, and
MURF3isubiquitouslydistributedinbothtypeIandIIﬁbres.
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Introduction
Protein turnover is a highly selective and tightly coordi-
nated process. In skeletal muscle, where the rates of protein
synthesis and degradation need to be carefully balanced
under different physiological stimuli to achieve muscle
plasticity, proteolysis is mediated mainly by the ubiquitin–
proteasome system (UPS), and the autophagy/lysosomal
system (reviewed in Sandri (2008)). Both pathways remove
misfolded or damaged proteins, but also functional pro-
teins, which must be simultaneously replaced by their
related isoforms––such isoform switching is critical for the
postnatal maturation and physiological adaptation of mus-
cle (reviewed in Schiafﬁno et al. (2008)) but also for the
maintenance of differentiated muscle (Masiero et al. 2009).
During UPS-mediated protein turnover, the targeted
substrate is covalently modiﬁed by the attachment of the
small peptide ubiquitin, via an enzymatic cascade whose
speciﬁcity is determined by designated E3 ligases. Where,
when and which protein is degraded therefore depends on
the expression status of its dedicated E3 ligase. In muscle,
multiple E3 ligases have been identiﬁed, known as atrog-
enes––of which the main ones are the F-box protein atro-
gin1/MAFbx and the MURF (muscle-speciﬁc ring ﬁnger)/
TRIM (RING/B-box/coiled-coil or tripartite motif con-
taining) family of proteins (reviewed in (Glass and Ro-
ubenoff 2010; Willis et al. 2009)).
The MURF family was ﬁrst identiﬁed by the interaction
of one of its members, MURF3, with serum response factor
(SRF) in a yeast two-hybrid screen (Spencer et al. 2000).
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MURF2/TRIM55; MURF3/TRIM54) encode highly homol-
ogous proteins, which can homo- and hetero-dimerise via
their coiled-coil domains (Centner et al. 2001). Differential
splicing occurs in the C-termini of some MURF genes,
producing isoforms with tissue-speciﬁc expression pat-
terns, particularly evident in the case of MURF2, of which
at least four isoforms are expressed in human and mouse
(Perera et al. 2011; Pizon et al. 2002). At least three of
these isoforms are expressed in skeletal muscle (MURF2
p60A, p60B and p50A), while a small splice variant, p27A,
lacking the coiled-coil domain that mediates hetero- and
homodimerisation of TRIM E3 ligases, is expressed in the
heart of mice and men (Perera et al. 2011; Pizon et al.
2002). In contrast, MURF1 does not seem to be differen-
tially spliced, and only one variant has been reported for
MURF3 (Centner et al. 2001; Spencer et al. 2000). Inter-
actions of MURF1 and MURF2 with domains near the
C-terminus of titin lead to association with the M-band
(Centner et al. 2001; Pizon et al. 2002). However, MURF1
and MURF2 and likely also MURF3 can translocate to the
nucleus during atrophic stress in cardiomyocytes (Lange
et al. 2005; Pizon et al. 2002) and in skeletal muscle in vivo
(Lange et al. 2005; Ochala et al. 2011), where they appear
to act as repressors of muscle gene expression. MURF1 and
MURF3 have also been found at the Z-disk (Centner et al.
2001; Spencer et al. 2000), indicating that the sarcomeric
targeting of MURFs is not only dependent on M-band titin
interactions, and that atrophic signalling can strongly
inﬂuence their localisation. In addition, MURF2 and
MURF3 were shown to colocalise with stable glutamylated
microtubules during myoﬁbrillar assembly in vitro (Pizon
et al. 2002; Spencer et al. 2000), and also at the earliest
stages of cardiac myoﬁbrillogenesis in vivo (Perera et al.
2011). During myogenic differentiation, stable arrays of
glutamylated microtubules accumulate with a simultaneous
reduction of the dynamic tyrosinated tubulin pool (Gun-
dersen et al. 1989) and seem to be involved in the active
transport of sarcomeric proteins to the sites of myoﬁbril-
logenesis (Pizon et al. 2005). Together, these observations
suggest that the association of MURFs with microtu-
bules could regulate their stability, facilitating muscle
differentiation.
In the sarcomere, MURFs form an M-band associated
signalling module together with titin kinase and its asso-
ciated scaffolds nbr1 and p62/SQSTM1 (Lange et al.
2005), both of which participate in ubiquitin-related sig-
nalling, as well as in the control of autophagy (Bjorkoy
et al. 2005; Kirkin et al. 2009; Komatsu et al. 2007; Waters
et al. 2009). In autophagy, proteins targeted for degradation
by ubiquitin modiﬁcation usually bear lysine-63 linked
polyubiquitin chains, and are recruited to autophagosomes
containing lipidated LC3 at their membranes by speciﬁc
adapter proteins binding both ubiquitin and LC3 (Geng and
Klionsky 2008). Proteasomal degradation predominantly
removes proteins labelled with lysine-48 linked chains.
MURFs therefore not only associate with different cyto-
skeleton components such as microtubules, Z-disks and
M-bands, as well as with metabolic enzymes and nuclear
proteins, but seem to cooperate with diverse proteins
implicated in selective protein degradation by the protea-
some and autophagosome, and to target proteins of meta-
bolic regulation, sarcomere assembly and transcriptional
regulation (Lange et al. 2005; Witt et al. 2005).
Only for MURF1 has an association with mature type II
(fast) ﬁbres been shown (Moriscot et al. 2010), and com-
bined ablation of MURF1 and MURF2 were reported to
affect postnatal muscle growth, metabolism, and ﬁbre-type
differentiation (Moriscot et al. 2010; Witt et al. 2008).
Whilst considerable data have emerged on the atrophy-
related function of MURFs, with almost complete focus on
MURF1, the expression proﬁle of these highly cooperative
and perhaps partly redundant proteins during skeletal
muscle development and postnatal differentiation is sur-
prisingly largely unknown. Therefore, we studied the
expression proﬁle of MURFs and their associated UPS/
autophagy-linked binding partners during skeletal muscle
development and probed the functions of MURF2 p50, the
dominant MURF during development, by short-term siR-
NA-mediated knockdown.
Materials and methods
Analysis of MURF transcripts
RNA was extracted from freshly isolated tissues of healthy
C57BL/6 mice using the RNeasy Mini Kit (Qiagen, UK).
cDNA was prepared in a total reaction volume of 20 ll
using 2 lg of total RNA, utilising the Super-Script III RT-
PCR Kit (Invitrogen, UK). 2 ll of cDNA was ampliﬁed in
aﬁ n a l5 0ll reaction. The primers used were:
MURF1
For 50-CCGCTCGAGCCACCATGGATTATAAATCT
AGCCTG,
Rev 50-TTTTTTGGATCCCCTTGGTGTTCTTCTTTA
CCCTC;
MURF2
For 50-CCGCTCGAGCCACCATGAGCACTTCTCTG
AATTACAAG,
Rev 50-TTTTCCCGGGCACCTTCATTTAGGGAATT
CAACC;
p62/SQSTM1
For 50-GGAGGAGCTCGAGCCATGGCGTTCACGGT
GAA,
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GGTGTTCG;
LC3B
For 50-CGGAGCTTTGAACAAAGAGTG,
Rev 50-GTCCCGAATGTCTCCTGCG;
nbr1
For 50-ATGGAACCACAGGTTACTCTA,
Rev 50-GCAGAAGAACATTGCTCTGG.
For analysis of relative transcript levels by semi-quan-
titative RT-PCR, glyceraldehyde-3-phosphate (GAPDH)
was used as a loading control, with the primers
For 50-GGCACTGTCAAGGCTGAAAACG
Rev 50- GGAGATGAGATGATACCACGCTTAG.
All reactions were done in triplicate and relative
expression was quantiﬁed by Image-J software (National
Institute of Health, USA).
Western blotting
Snap-frozen tissue samples were homogenised by freeze-
slamming, dissolved in SDS-sample buffer (3.7 M Urea,
134.6 mM Tris, 5.4 % SDS, 2.3 % NP-40, 4.45 % b-
mercaptoethanol, 4 % glycerol, 6 mg/100 ml bromophenol
blue, pH 6.8) and boiled for 2 min. Preparations were run on
10 or 12 % polyacrylamide minigels and separated proteins
were either immediately visualised by Coomassie blue
staining (loading) or blotted onto nitrocellulose Protran BA-
83, (Schleicher & Schuell, Germany) overnight in transfer
buffer (3 g Trizma base, 14.5 g glycine, 0.1 g SDS, 200 ml
methanol) at 60 mA in a wet-blot transfer unit (Biorad, UK).
Protein transfer was conﬁrmed by Ponceau-S staining.
The membrane was blocked by incubating for 1 h in low-
saltbuffer(0.9 %NaCl,0.1 %Tween-20,50 mMTrispH7.4)
supplemented with 5 % non-fat milk powder. The membrane
wasincubatedinprimaryantibodyfor2 hatroomtemperature
orovernightat4 C;theblotwaswashed3 9 5 mininlow-salt
buffer containing 1 % non-fat milk powder; and subsequently
incubated in secondary antibody for 1 h at room temperature.
Chemiluminescence reaction was performed using homemade
developing solution (7.5 ml H20, 1 ml 25 mM 5-amino-2,3-
dihydro-1,4-phthalazinedione, 1 ml 5 mM 4-Iodophenol,
0.5 ml 1 M Tris pH 7.5) and visualised on Hyperﬁlm ECL
(Amersham,USA).DensitometrywasperformedusingImageJ
software (National Institute of Health, USA).
Cell culture and immunoﬂuorescence
For C2C12 transfections, approximately 1.5 lgo fp l a s m i d
DNA was diluted in 30 llo fD M E M ,6ll of Lipofect-
amine2000(Invitrogen,UK)wasseparatelymixedinanother
30 ll of DMEM. The DNA and Lipofectamine2000 were
mixedtogetherandlefttocomplexfor30–40 min.Cellswere
washed twice with DMEM. The DNA-Lipofectamine2000
mixwasaddedﬁrsttothecells,swirledfor1 min,then0.8 ml
of DMEM was added per 35 mm culture dish. Cells were
incubatedfor4–6 hat37 Cin5%CO 2.Cellswerechanged
to 1.5 ml of C2C12 differentiating medium. Cells were ﬁxed
with 4 %-paraformaldehyde (PFA)/PBS at required time
points. If cells were intended for microtubule staining, they
were washed twice with microtubule protection (MP) buffer
(65 mM PIPES, 25 mM HEPES, 10 mM EGTA, 3 mM
MgCl2,pH6.9),andﬁxedwith4 %PFA/MPbuffer.Samples
were permeabilised with 0.2 % Triton X-100 in PBS for
5 min.PrimaryandsecondaryantibodiesweredilutedinGold
buffer (20 mM Tris-base, 155 mM NaCl, 2 mM EGTA,
2m MM g C l 2 pH 7.5) containing 5 % BSA. Cells were
incubatedinprimaryantibodiesfor1 hatroomtemperatureor
overnightat4 C,theninsecondaryantibodiesfor1 hatroom
temperature.Specimensweremountedin0.1 MTris–HClpH
9.5-glycerol (3:7) including 50 mg/ml n-propyl-gallate as
anti-fading reagent (Messerli et al. 1993) and viewed on a
Zeiss LSM Meta 510 confocal microscope equipped with an
Argon-laser, Helium–Neon-lasers and UV-diode.
Cryosectioning and immunoﬂuorescence
Perinatal and adult mouse gastrocnemius and soleus were
freshly isolated, mounted in cryosectioning medium and
immediately submerged in liquid isopentane in liquid
nitrogen. Samples were then stored at -80 C until cryo-
sectioning. Before sectioning, samples were ﬁrst placed in
the cryostat cold chamber for 1 h to equilibrate. Samples
were embedded and 10–20 lm sections were cut. Samples
were allowed to dry for 1–2 h, then directly ﬁxed with 4 %
PFA/PBS for 2 min, permeabilised with 0.2 % Triton
X-100 in PBS for 1 min, blocked for 30 min with normal
horse serum (NHS) in 1 % BSA/gold buffer solution, and
then incubated for 1 h at room temperature with primary
antibody. After 3 9 5 min washes with PBS, secondary
antibody was added for another 1 h at room temperature.
Samples were mounted as previously described (Messerli
et al. 1993).
siRNA experiments
Isoform-speciﬁc 19-mer target siRNA were designed
against mouse- and rat-speciﬁc sequences (identical for
both species) that bridged the unique exon–exon bound-
aries for MURF2 p50A and p60A, which corresponded to
exons 8–11 and exons 9–11 respectively, as obtained from
the NCBI database. For p60A knockdown,
FOR 50-gatccccGCTACCTCTCAGATTGGATttcaaga-
gaATCCAATCTGAGAGGTAGCtttttggaac-30
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REV 50-gttccaaaaaGCTACCTCTCAGATTGGATtctc
ttgaaATCCAATCTGAGAGGTAGCggggatc-30 were used.
For p50A knockdown,
FOR 50-gatccccCTGGTGACACAGATTGGATttcaaga-
gaATCCAATCTGTGTCACCAGtttttggaac-30
and
REV 50-gttccaaaaaCTGGTGACACAGATTGGATtctctt-
gaaATCCAATCTGTGTCACCAGggggatc-30 were
used. For controls, scrambled sequences were used.
The H1-GFP vector used is based on pSuper
((Brummelkamp et al. 2002); H1 RNA-Pol III promoter)
and pEGFP (Clontech; EGFP under the control of the CMV
promoter). This ensures that the siRNA is expressed con-
currently with GFP, which allows for easy identiﬁcation of
transfected cells. The forward and reverse primers for
siRNA were dissolved in 50 ll of water; and self-annealed
using 2 ll of each oligonucleotide and 46 ll of annealing
buffer (100 mM potassium acetate, 30 mM HEPES–KOH
pH 7.4, 2 mM magnesium acetate) to give double-stranded
constructs. Construct speciﬁcity and knockdown efﬁciency
was tested by transfecting the siRNA into COS-1 cells,
along with a plasmid that expressed either GFP-mouse
MURF2 p60A or p50A, and assessing the reduction of the
speciﬁc target protein by Western blotting. For expression
of these GFP-fusion proteins, full-length mouse MURF2
cDNA was PCR-ampliﬁed as explained previously, and the
products were cloned into the pEGFP-C1 vector (Clon-
tech). Western blots of knockdown efﬁciency were previ-
ously described (Perera et al. 2011). Statistical analysis was
performed by GraphPad Instat3 software.
Antibodies
For Western blotting, the commercial goat anti-MURF2A
(Abcam ab4387, 1:500), rabbit anti-HPC (1:2,000, Pizon
et al. 2002) and rabbit anti-HP60 (1:2,000, Pizon et al.
2002) antibodies were used (see Supplemental Fig. 1 for
epitope localisations). Additionally, rabbit anti-p62/Se-
questosome1 (Abcam ab56416, 1:500), rabbit anti-LC3B
(Cell Signalling #2775, 1:500), mouse monoclonal anti-
nbr1 (Abcam ab55474, 1:500), rabbit anti-SRF (Santa-Cruz
SC13029, 1:500), goat anti-MuRF3 (Santa-Cruz SC50252,
1:500), rabbit anti-GAPDH (Abcam ab9485, 1:1,000) and
rabbit anti-actin (Sigma A2066, 1:1,500) antibodies were
used. As secondary antibodies, HRP-conjugated rabbit
anti-goat IgG and goat anti-rabbit IgG from Calbiochem
(1:1,000); and HRP-conjugated rabbit anti mouse IgG
(Dako, 1:1,000) were used.
For immunoﬂuorescence, MURF2 was visualised with the
goat anti-MURF2A (1:100), rabbit anti-HPC (1:100), and
rabbitanti-HP60(1:200)antibodies.Additionally,rabbitanti-
sarcomeric a-actinin, rat anti-all tubulin (Abcam, clone
YOL1/34, 1:100), mouse anti-glutamylated a-tubulin (Syn-
aptic systems, clone 1D5, 1:200), rat anti-tyrosinated tubulin
(Abcam, clone YL1/2, 1:200), mouse anti-acetylated a-tubu-
lin (Abcam ab24610, clone 6-11B-1, 1:100) and mouse anti-
multiubiquitin(StressgenSPA-205E,cloneFK2,1:100)were
used. The mouse anti-all MyHC A4.1025 and anti-slow
MyHC A4.840 antibodies were kindly donated by Dr.
S. Hughes (Hughes et al. 1993), whilst the mouse anti-my-
omesin B4 antibody was a gift of Dr. E. Ehler (Grove et al.
1984).Fortriplestaining,combinationsofAlexa488,Cy3and
Cy5-conjugated secondary antibodies were used. Cy3 anti-
goat Ig, Cy3 anti-mouse Ig, Cy5 anti-mouse Ig, Cy5 anti-
rabbit Ig, Cy3 anti-rabbit Ig, Cy5-anti rat Ig were purchased
fromStratechScientiﬁc,USAandthesubclassspeciﬁcFITC-
antimouseIgM(forA4.840)waspurchasedfromSigma,UK.
Results
MURF2 isoforms undergo pre- and postnatal switching
and overall downregulation in developing skeletal
muscle
MURF2, which is alternatively spliced to generate multiple
isoforms in both human and mouse (Perera et al. 2011;
Pizon et al. 2002), is expressed in embryonic mouse skel-
etal mouse as early as E13.5–E15.5, as detected by the
commercially available, goat anti-MURF2A-speciﬁc anti-
body, as two bands corresponding to the p60A and p50A
isoforms (Supp. Fig. 1; Fig.1a). Identical results were
obtained with a generic antibody with overlapping epi-
topes, HPC. During embryonic stages, the 50 kDa isoform
dominates; however, there is a transition to the 60 kDa
isoform during postnatal development, such that in adult
gastrocnemius muscle, the p50A isoform can only be
detected at very high exposures (Fig. 1a, Supplemental
Fig. 2). The overall levels of both MURF2-A isoforms are
reduced in adult skeletal muscle (Fig. 1a, b).
Fig. 1 Developmental expression of MURF E3 ubiquitin ligases and
related UPS/autophagy proteins in mouse skeletal muscle. a Western
blot analysis of mouse skeletal muscle lysates (gastrocnemius) from
embryonic (E) to postnatal (P) stages. b Plot of the densitometric
analysis on Western blots normalised for GAPDH levels. c Semi-
quantitative RT-PCR on cDNA isolated from mouse gastrocnemius.
d Plot of semi-quantitative RT-PCR data obtained from three
independent sets of experiments; error bars represent standard
deviation. e Western blots showing the differential expression of
MURF2 isoforms between predominantly fast (tibialis anterior––TA)
and slow (soleus––SOL) muscle from P0 to adult stages. Note that
p50 remains detectable postnatally only in soleus muscle
c
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uitin ligases (Centner et al. 2001) and their predicted func-
tions in muscle protein turnover (Willis et al. 2009), we
exploredtheexpressionproﬁleofallMURFfamilymembers
andtheirfunctionallyassociatedcomponentsoftheUPSand
autophagy/lysosomal systems. Protein levels of LC3B, nbr1
and p62/SQSTM1 peak at E15.5 and are then gradually
downregulated (Fig. 1a, b). RT-PCR analysis shows a sim-
ilarexpressionproﬁle(SupplementalFig. 3A-B),suggesting
that ubiquitin- and autophagy-mediated protein turnover are
tightly and co-ordinately regulated during early skeletal
muscle development. SRF, a known target of MURF2
(Lange et al. 2005) and ligand of MURF3 (Spencer et al.
2000), and a mediator of muscle remodelling in response to
hypertrophic stimuli (Carson and Booth 1998; Fluck et al.
2000; Gordon et al. 2001), is also expressed embryonically,
but is surprisingly rapidly downregulated, possibly in par-
allel with increasing levels of MURF2 (Fig. 1a, b). MURF3
is only detected postnatally with the available antibody,
implying that time-dependent regulation of the family of
MURF E3 ubiquitin ligases could be functionally relevant
(Fig. 1a, b). We also compared MURF1 and MURF2 mes-
sage levels over time and found that although MURF1 is
presentembryonically,itisdramaticallyupregulatedatbirth
and maintained at elevated levels thereafter (Fig. 1c, d).
Taken together, these results suggest that MURF1 and
MURF2 are dynamically regulated during embryonic skel-
etal muscle development, with MURF3 expression becom-
ingnotableonlypostnatally.Thepostnatalisoformswitchin
MURF2 and overall developmental downregulation mirrors
previous observations during cardiac muscle differentiation
(Perera et al. 2011).
MURFs show ﬁbre-type speciﬁc expression
As the establishment of fast and slow ﬁbre subtypes is a
key process during skeletal muscle development governing
later muscle function, we asked whether MURFs exhibit
ﬁbre-type-speciﬁc expression.
Lysates of fast and slow muscles, tibialis anterior (TA) and
soleus(SOL),werestudiedbyWesternblots,anddensitometric
analysis of these was performed. At P0, MURF2 p50A and
p60A are abundant in both muscles; however as development
proceeds, p50A levels are strongly downregulated in the TA,
more so than in the soleus (Fig. 1e, f). In the adult, only trace
amountsofp50AaredetectedintheTA,whichisincontrastto
the soleus that has approximately 3-fold higher expression
levels of p50A (Fig. 1e, f). The adult soleus also shows
noticeably higher levels of p60A compared to the TA (Fig. 1e,
f). Given that slow ﬁbres are absent in the adult TA, this sug-
gests that MURF2 p50A is strongly slow-ﬁbre-associated.
To investigate this ﬁbre-type speciﬁcity on the mor-
phological level, immunoﬂuorescence was performed on
cryosectioned skeletal muscle (mixed ﬁbre type, gastroc-
nemius). At P0, MURF2-A is ubiquitously present in all
ﬁbres (Fig. 2a, b) although slow ﬁbres can already be
detected by myosin staining in deeper regions of the
muscle in agreement with previous results (Allen and
Leinwand 2001). By P7 however, MURF2, as detected by
the A-isoform speciﬁc HPC antibody, appears to be pre-
dominantly within slow ﬁbres (Fig. 2c). Interestingly, the
MURF2-p60A/B-speciﬁc HP60 antibody staining gives a
more widespread signal at P7, which is possibly due to the
MURF2 p60B isoform being ubiquitously distributed
(Fig. 2d). In the adult, HPC-detected MURF2-A isoforms
are again predominantly localised in slow ﬁbres whilst the
HP60 signal is again more homogeneous (Fig. 2e, f). This
is in agreement with our Western blot data which shows
that p50A is slow-ﬁbre restricted and that p60A levels are
also appreciably higher in slow muscle (Fig. 1f). It seems
therefore that p60A levels are also more concentrated in
slow ﬁbres. In summary, MURF2-A isoforms are tightly
developmentally regulated and p50A in particular assumes
slow-ﬁbre speciﬁc localisation during ﬁbre subtype matu-
ration, arguing for roles in both skeletal muscle differen-
tiation and postnatal maturation.
MURF1 was recently shown to be fast (type II) ﬁbre-
associated in skeletal muscle, and a double knockout model
(dKO) of both MURF1/2 appeared to shift the ﬁbre balance
towards slow (type I) ﬁbres in the soleus (Moriscot et al.
2010). However, these authors did not investigate MURF2
or MURF3 expression; hence, we set out to ﬁll this missing
gap in the understanding of ﬁbre-type speciﬁc MURF
functions by comparing all three MURFs at the ﬁbre level.
Interestingly, whilst MURF2-A isoforms are highly
expressed in the slow myosin-positive ﬁbres in adult soleus
(Fig. 3a), MURF1 is largely excluded from these slow
ﬁbres (Fig. 3b) in agreement with (Moriscot et al. 2010),
while MURF3 is ubiquitously detected in all ﬁbre types
(Fig. 3c).
Fig. 2 Fibre-type restriction of MURF2 expression. Cross-sections of
gastrocnemius muscle were analysed by immunoﬂuorescence micros-
copy. a, b MURF2 is ubiquitously present in all muscle ﬁbres at P0,
as detected by both the A-isoform speciﬁc HPC antibody and the
p60A/B-speciﬁc HP60 antibody. c By P7, MURF2-A isoforms show
slow-ﬁbre expression. d At P7, the HP60 antibody shows that MURF2
p60A and B are more widely distributed. e, f In adult muscle,
MURF2-A isoforms are again predominantly slow-ﬁbre associated
whilst HP60 staining gives a more widespread signal. Slow ﬁbres
were stained with monoclonal anti-slow myosin antibody A4.840, all
myosin isoforms were visualised by the monoclonal anti- myosin
antibody A1025. Scale bars 20 lm
c
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and in vivo during skeletal muscle differentiation
Whilst these data provided a comprehensive understanding
of the in vivo developmental regulation of MURFs, it was
nevertheless important to verify that the expression proﬁle
was consistent in in vitro models for experimental pur-
poses. We studied the expression pattern of MURFs and
their related UPS- and autophagy-linked proteins in the
mouse-derived C2C12 cell line as differentiation pro-
gressed, and found that MURFs are not expressed in pro-
liferating myoblasts, however upon serum withdrawal, all
three MURF isogenes are induced (Fig. 4a, b). It is note-
worthy, however, that both message and protein levels of
MURF1 and MURF3 lag behind those of MURF2 (Fig. 4a,
b). All three MURFs are consistently upregulated during
differentiation until day 8, after which their levels decline
(Fig. 4a, b). The sequential appearance of MURF2 p50A
Fig. 3 MURF family members have differential ﬁbre-type-speciﬁc
expression. a MURF2-A isoforms are strongly detected in type I/slow
ﬁbres stained by the monoclonal anti-slow myosin antibody A4.840.
b MURF1 appears to be excluded from the slow ﬁbres. c MURF3 is
ubiquitously present in both fast and slow ﬁbres. Cryosectioned
samples of adult soleus were stained, and imaged by confocal
microscopy. Scale bars 20 lm
Fig. 4 MURF expression is consistent both in vivo and in vitro and
loss of MURF2 delays myogenic differentiation. a Analysis of
MURFs and related UPS- and autophagy proteins in the murine
C2C12 cell line as differentiation progressed. b Densitometric
analysis of the Western blots normalised to GAPDH levels.
c MURF2 is not detected in dividing myoblasts in vitro. d Serum
withdrawal results in dramatic upregulation of MURF2-A isoforms at
day 2 of myoblast differentiation. e SiRNA knockdown of MURF2
p50A or p60A results in signiﬁcantly reduced fusion indexes for
differentiating myoblasts. Myoblasts were considered to be differen-
tiated if they had multiple nuclei and made cell-to-cell contacts with
neighbouring cells. By day 3, degree of differentiation in cultures
transfected with p50A- or p60A-speciﬁc siRNA were signiﬁcantly
lower than controls (p\0.01). f By day 5, these cells were
recovering and catching up with controls, however p60A-knockdown
cultures still lagged behind controls (p\0.05). g By day 7, control
and siRNA-transfected myotubes possess similar degrees of differ-
entiation. Data given as the mean percentage of transfected fused
myotubes, obtained by counting [40 myoblasts from three sets of
experiments. Error bars represent standard deviation. Statistical
analysis was done by One-way ANOVA
c
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123before p60A seen in vivo (Fig. 1) is less pronounced in
cultured cells, however; both isoforms are more or less co-
expressed after day 2. The cardiac MURF2 p27A isoform
was not detectable. As by immunoﬂuorescence analysis,
MURF2-A isoforms are again absent at day 0 (Fig. 4c) but
are strongly induced in the cytoplasm of differentiating
cells by day 2 (Fig. 4d). In agreement with all previous
results, MURF2 could be detected in differentiating myo-
blasts in the cytoplasm, but the nuclei showed no signiﬁ-
cant staining.
Knockdown of MURF2 isoforms leads to delayed
myogenic differentiation in vitro
We therefore asked whether MURF2 isoforms had distinct
roles during skeletal muscle differentiation, by employing a
small interfering RNA approach (Brummelkamp et al.
2002), speciﬁcally targeting either the p50A or p60A iso-
forms (described in (Perera et al. 2011)). The siRNAs were
expressed from a modiﬁed H1-GFP plasmid (Brummelk-
amp et al. 2002) that also encodes for GFP to enable
identiﬁcation of transfected cells. Due to the highly limited
target sites for isoform-speciﬁc knockdown at the splice
boundaries, only one siRNA could be designed for MURF2
p50 or p60 knockdown. However, our previous results
showed that the cellular effects of these siRNA in neonatal
cardiomyocytes could be rescued by transfection with
siRNA-resistant MURF2 p50 cDNA (Perera et al. 2011).
Proliferating myoblasts were transfected with the siRNAs
or a scrambled control siRNA, then serum was withdrawn
and the cells were allowed to differentiate. After 3 days,
cultures transfected with either p50A- or p60A-speciﬁc
siRNA showed signiﬁcantly reduced levels of myoblast
fusion and myotube formation (Fig. 4e, p\0.001). After
5 days, these myoblasts appeared to recover, as the extent
of fusion and myotube differentiation is noticeably
increased, although still lagging behind control cultures
(Fig. 4f, p B 0.005). Analysis after 1 week demonstrated
that the differentiation of cultures transfected with either
isoform-speciﬁc or control siRNA are comparable
(Fig. 4g), possibly because of gradual loss of the siRNA
plasmid, or upregulation of compensatory MURF isogenes.
The observation that both MURF2 p60 and p50 siRNAs
had comparable effects, compared to control siRNA,
agrees with the roughly equal expression levels of both
isoforms (Fig. 4a).
Knockdown of MURF2 disrupts de novo
myoﬁbrillogenesis in differentiating myoblasts
We next considered whether the lag in differentiation
observed in the C2C12 cell line would be reﬂected at the
cellular level by staining for sarcomeric a-actinin, a
Z-disk marker, which is one of the ﬁrst sarcomeric pro-
teins to be expressed in differentiating myoblasts and also
one of the ﬁrst components to be integrated into organised
sarcomeric complexes during myoﬁbrillogenesis (Sanger
et al. 2005, 2010). As expected, in control cells at day 2
of differentiation, both a-actinin and MURF2 expression
is strongly upregulated in myoblasts that have started to
differentiate, elongate and fuse (Fig. 5a). However, in
myoblasts transfected with p50A-speciﬁc siRNA, a-acti-
nin staining is reduced both after 2 (Fig. 5b) and 5 days
of differentiation (not shown). These observations suggest
that cytoskeletal remodelling during myoﬁbril assembly is
perturbed by the short-term knockdown of MURF2 p50A.
We therefore asked whether this affected also the tran-
sient scaffolds of myoﬁbril assembly, the microtubule
network.
Loss of MURF2 is associated with perturbed stable
microtubules in differentiating myoblasts
Myogenic differentiation is characterised by the formation
of stable arrays of glutamylated tubulin, with a simulta-
neous reduction in the dynamic pool of tyrosinated tubulin
(Gundersen et al. 1989); and MURF2 was previously
shown to associate with microtubules in a skeletal muscle
cell line prior to the formation of mature myoﬁbrils (Pizon
et al. 2002). In addition, it was recently shown that MURF2
colocalises with glutamylated microtubules also in vivo at
the earliest stages of cardiac differentiation. Lastly,
knockdown of MURF2 in neonatal rat cardiomyocytes
perturbed their stable microtubule population (Perera et al.
2011). This led us to hypothesise that the observed delay in
myotube formation and de novo myoﬁbrillogenesis may at
least in part be due to disrupted microtubule organisation.
Hence, we looked at both the stable and dynamic fractions
of microtubules during myoblast differentiation in vitro.
We found that MURF2 is strongly colocalised with stable
glutamylated and acetylated microtubules (Fig. 6a, b), but
not with the dynamic tyrosinated population (Fig. 6c),
which agrees well with previous ﬁndings in cardiomyo-
cytes. We then looked at myoblasts transfected with p50A-
speciﬁc siRNA. Here, the stable, glutamylated microtu-
bules are noticeably reduced and are also not organised in
parallel arrays (Fig. 6d), whereas the dynamic tyrosinated
microtubule pool seemed unaffected (Fig. 6e). Taken
together, our data support the conclusion that MURF2
functions in the earliest steps of myoblast differentiation
and myoﬁbrillar assembly, possibly via the ubiquitylation
of microtubule-modifying complexes, which are crucial for
achieving and/or maintaining the required stability of
microtubules.
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While the widely established function of the UPS and
autophagy/lysosomal systems is proteolytic breakdown
associated with catabolic muscle mass loss (Glass 2005), it
is now becoming apparent that this is an over-simpliﬁca-
tion of a highly complex, tightly regulated process, which
is also important during early development, for the ordered
protein turnover required for muscle plasticity (Sandri
2010; Schiafﬁno et al. 2008), or during stress response
(Willis et al. 2009, 2010).
The recent identiﬁcation of muscle E3 ubiquitin ligases
that target key cardiac transcription factors such as Nkx2.5
or phosphorylated c-Jun, which are critical to cardiac
development and homeostasis, highlights the importance of
the UPS in the earliest stages of striated muscle differen-
tiation (Jang et al. 2011) and in stress response (Li et al.
2011). Furthermore, the discovery that the widely expres-
sed E3 ubiquitin ligase RNF13 (whose levels are strongly
reduced during skeletal muscle development) is important
in limiting myoblast proliferation also underscores the
relevance of this system to the regulation of skeletal muscle
differentiation (Zhang et al. 2010). Dedicated E3 ligases
therefore play roles far more complex than just in the
induction of an atrophy programme of muscle protein
degradation. Indeed, combined knockout mice for MURF1/
2 (Witt et al. 2008) or MURF1/3 (Fielitz et al. 2007) show
both pre- and postnatal phenotypes that indicate crucial and
only partly redundant roles of MURF- mediated ubiquity-
lation of metabolic, sarcomeric and signalling proteins
during muscle growth and homeostasis.
Similarly, an essential role of autophagy in early embryo
differentiation has been identiﬁed using Atg5-/- mice
(Tsukamoto et al. 2008). Later stages of mammalian
embryonic development also require autophagy for con-
trolling cell numbers, as mice with a targeted deletion of
the autophagy-related gene beclin1 die between E7.5 and
8.5 (Yue et al. 2003). Postnatal inhibition of autophagy in
skeletal muscle also promotes accumulation of toxic pro-
teins, and surprisingly does not protect from atrophy, but
instead causes muscle loss (Masiero et al. 2009; Masiero
and Sandri 2010). These ﬁndings suggest that although yet
poorly understood, the UPS and autophagy/lysosomal
systems of proteolytic turnover are also essential regulators
of development, maintenance and remodelling in muscle.
Whilst the atrophy-related function of MURFs has been
well documented (reviewed in (Foletta et al. 2011; Sandri
2008), their roles in development are largely ignored. We
have previously shown that MURF2 is the earliest MURF
isogene to be expressed in differentiating myocardium, and
that its targeted knockdown in cardiomyocytes results in
disruption of sarcomere formation (Perera et al. 2011).
Loss of MURF2 can be partly compensated by upregula-
tion of MURF3, but compound loss of MURF2/MURF3 by
Fig. 5 siRNA knockdown of MURF2 p50A leads to sarcomeric
disassembly in vitro. a MURF2 and a-actinin (Z-disk marker) are
strongly upregulated in differentiating myoblasts at day 2 of serum
withdrawal. The 2-fold magniﬁed insert shows a-actinin appearing
in the ﬁrst cytoskeletal structures. Note that neighbouring, non-
differentiating cells do not express MURF2 and a-actinin, only their
nuclei are visible. b Knockdown of MURF2 p50A in differentiating
C2C12 cells results in reduced a-actinin levels and organisation at
2 days. Scale bars 10 lm
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modiﬁcations in differentiating myoblasts in vitro. a, c MURF2 is
strongly colocalised with the glutamylated and acetylated microtubule
populations (stable) in differentiating C2C12 cells, but not with the
dynamic tyrosinated fraction. Inserts in a, b: 92 magniﬁed regions
showing colocalisation (yellow in overlay) with glutamylated and
acetylated microtubules but not the tyrosinated fraction. d Knockdown
of p50A leads to decreased levels and organisation of the stable,
glutamylated microtubule population in myoblasts at day 2 of
differentiation. The image is overexposed to show the weak residual
staining for glutamylated tubulin. e In contrast, the dynamic,
tyrosinated microtubule pool appears unaffected by loss of p50A.
Scale bars 10 lm
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more severe myoﬁbrillar phenotype than the individual
knockdown of either isogene, suggesting partial compen-
sation afforded in vitro by these homologues (Perera et al.
2011). MURF2 was found to be closely associated with the
stable, glutamylated microtubule population important for
myogenic differentiation (McElhinny et al. 2004; Perera
et al. 2011; Pizon et al. 2002), a property observed also for
MURF3 (Spencer et al. 2000), which might explain why
MURFs might be required also during early skeletal mus-
cle formation. We therefore analysed the expression proﬁle
of MURFs and the functionally associated autophagy/
lysosomal machinery during skeletal muscle development.
Our results show that these UPS and autophagy compo-
nents are expressed at the earliest detectable stages of
differentiated skeletal muscle, with MURF2 being the
predominant MURF in the embryonic limb until birth.
Unlike in the heart (Perera et al. 2011), MURF expression
is not detected in the limb at E9.5, as myogenic differen-
tiation of limb muscle lags behind the heart. From birth
onwards, MURF1 and MURF3 levels are increased, whilst
MURF2 gets downregulated, suggesting that the different
MURF genes have time-dependent functions in skeletal
muscle. Our observation that SRF, a known target of
MURF2 (Lange et al. 2005) and an important regulator of
postnatal growth (reviewed in (Braun and Gautel 2011;
Charvet et al. 2006; Miano 2010), is reduced concomitantly
with increasing MURF2 levels, suggests tentatively that
MURFs might participate in protein homeostasis also on
the transcriptional level during developmental and post-
natal muscle remodelling. Fibre populations expressing
slow but not neonatal MyHC are detectable prenatally in
the rat. These differ from ﬁbres expressing neonatal but not
slow MyHC, which ultimately become fast ﬁbres (Condon
et al. 1990). However, the slow-ﬁbre association of
MURF2 appears after the determination of the contractile
phenotype [as shown by slow myosin staining; (Allen and
Leinwand 2001; Fladby and Jansen 1990)], suggesting that
this switch is transcriptionally controlled upstream of
MURF2.
Interestingly, we observed that MURFs display variable
ﬁbre-type preferences: while MURF2 is predominantly
slow-ﬁbre associated, MURF1 is largely excluded from
these ﬁbres and MURF3 is ubiquitously present. Further-
more, MURF2 was downregulated postnatally, quite dra-
matically in the case of p50A, and the switch from the
50 kDa isoform to the 60 kDa isoform was complete by
postnatal day 16, which coincides with ﬁbre-type matura-
tion in skeletal muscle (Schiafﬁno 2010; Wirtz et al. 1983).
MURF1 was recently shown to be predominantly fast (type
II) ﬁbre-associated in skeletal muscle (Moriscot et al.
2010), and we show here that MURF2A is, in contrast,
preferentially expressed in slow, type I ﬁbres. These results
suggest that MURF isogenes, although highly homologous,
by virtue of their variable expression pattern in different
ﬁbre types have access to speciﬁc molecular targets, which
may be relevant to the maintenance of different ﬁbre
identities. This might be supported by the observation that
MURF1/2 double knockout animals show a marked loss of
type-II ﬁbres in soleus muscle (Moriscot et al. 2010).
However, the apparent presence of MURF2 p60B (Fig. 2d,
f), and MURF3 (Fig. 3c) in all ﬁbre types complicates the
observed phenotypes, and further analysis would ideally
require a speciﬁc antibody (currently unavailable) against
the highly hydrophobic C-terminus of the p60B isoform.
Our observations prompt some revision of current
assumptions about MURF function. MURF1 is widely
regarded as a marker of muscle atrophy, due to its early and
robust upregulation when muscle catabolism is triggered
by disuse, denervation, starvation, sepsis or steroid
administration (Glass and Roubenoff 2010; Sandri 2008).
Indeed, MURF1 was conﬁrmed as a major factor in muscle
atrophy when knockout mice for MURF-1 were shown to
be protected from denervation-induced atrophy (Bodine
et al. 2001). It is currently not known whether MURF2 or
MURF3 knockout mice are protected from atrophy, pos-
sibly in a manner restricted to slow ﬁbres in the case of
MURF2. However, as atrophic ﬁbres revert to a more
glycolytic, fast-ﬁbre phenotype (Schiafﬁno et al. 2007), the
atrophy-related upregulation of MURF1 might therefore
reﬂect as much the switch in ﬁbre type as the atrophic
process itself. Furthermore, the assumption that MURF1
and 2 target redundant sets of muscle proteins (Witt et al.
2008) seems to be contradicted by the different phenotypes
of the available dKO models, and requires complementing
future insight into their ﬁbre-type speciﬁc substrates or
regulation mechanisms.
The interaction of MURF1/2 with myozenin-1 was
proposed as a mechanism by which type-II ﬁbres could be
lost, as myozenins acts as a brake on calcineurin activity,
and MYOZ2 knockout mice show an excess of slow
skeletal muscle ﬁbres (reviewed in (Gautel 2008)). This
interpretation is also compatible with the observation that
the combined knockout of MURF1/2 also leads to postnatal
hypertrophic muscle growth (Witt et al. 2008).
Taken together, these results suggest that MURFs may
participate in establishing and/or maintaining ﬁbre-type
identities. The exact mechanism responsible is unclear, but
given that MURFs interact with multiple mitochondrial and
glycolytic enzymes, sarcomeric proteins, scaffold proteins
and transcription factors (Lange et al. 2005; Witt et al.
2005), altered energy metabolism and transcriptional or
post-translational regulation of contractile properties are
plausible pathways.
MURF2 was previously proposed to function as a
transient ‘‘adaptor’’ in myoﬁbrillogenesis in a skeletal
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ﬁrmed association of MURF2 with stable microtubules
during cardiac myoﬁbrillogenesis in vivo (Perera et al.
2011) further conﬁrmed that MURFs play an active role in
microtubule-mediated sarcomere assembly. Our knock-
down experiments with two different MURF2 siRNA in
C2C12 myoblasts show delayed myotube formation in
MURF2-lacking cells with associated disruption of stable
glutamylated microtubules, but the dynamic fraction of ty-
rosinated microtubules remained unaffected. This is
intriguing, because MURF3 has also been shown to asso-
ciate with glutamylated microtubules during skeletal muscle
development (Spencer et al. 2000). However, the upregu-
lation of MURF3 lags behind that of MURF2 (Fig. 1), and
full functional compensation in early myoblasts might
therefore not be possible. It is also conceivable that these
isogenes therefore cooperate in their microtubule-binding
roles, possibly via hetero-dimerisation. This hypothesis is
further supported by previous observations that MURF2 and
MURF3 show partial functional compensation in cardio-
myocytes in vitro (Perera et al. 2011). Surprisingly, studies
to date have not reported any obvious primary myoﬁbrillar
defects in single MURF2-/- mice (Willis et al. 2007); this
might again be due to functional compensation by other
MURF isogenes. The identities of the microtubule-associ-
ated enzymes performing microtubule modiﬁcations are
only just beginning to emerge; we speculate that controlled
ubiquitylation of such complexes might regulate microtu-
bule stability and therefore, allows myogenic differentiation
and sarcomerogenesis to proceed correctly.
In summary, we show that MURF ubiquitin E3 ligases
are tightly developmentally regulated in skeletal muscle,
with the p50A isoform of MURF2 being predominant at
embryonic stages; MURF1, MURF2 p60A, and MURF3
play roles mostly in postnatal stages. MURF1 and MURF2
show ﬁbre-type preference (MURF1 fast, MURF2A slow),
which argues for functional specialisation and a role in
deﬁning the contractile and metabolic properties of these
muscles. Ablation of MURF2 disrupts early stages of sar-
comere assembly in the C2C12 skeletal muscle model,
probably via perturbation of microtubule modiﬁcations
important for the establishment of a stable microtubule
network. Whilst it is important to realize that short-term
effects in isolated cells in culture may not necessarily be
reﬂected at the whole organism level, where multiple
compensatory mechanisms act over longer durations, the
study of dual MURF2/MURF3 knockout animals could be
informative in deciphering the degree of cooperation and
redundancy built into this highly specialised and multi-
functional protein family.
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